Font Size: a A A
Keyword [tyrosine kinase inhibitor]
Result: 21 - 40 | Page: 2 of 10
21. Antiproliferative Effects Of EGFR Tyrosine Kinase Inhibitor AG1478 On Human Renal Carcinoma Cell Line GRC-1
22. Study Of 4-anilinequinazoline Schiff Bases As Inhibitors Of Tyrosine Kinase Of The Epidermal Growth Factor Receptor
23. Computer-Aided Drug Design And Partial Synthesis Of Novel VEGF Receptor Inhibitors
24. STI571 For Bone Marrow Purging Ex Vivo In Chronic Myeloid Leukemia
25. Role Of Tyrosine Kinase Inhibitor IRESSA In Targeted Therapy Of Hepatocellular Carcinoma
26. The Effects Of Tyrosine-kinase Inhibitor On The RPMI8226 Cell Proliferation And Cell Adhesion Mediated Drug Resistance
27. Expression And Significance Of C-kit Receptor In Osteosarcoma
28. Screening And Identifying The Inhibitors Of Src Protein Tyrosine Kinase From Hedyotis Diffusa Willd
29. Study On Effects Of Protein Tyrosine Kinase Inhibitor Staurosporine In Gastric Carcinoma Cells
30. Radiosensitization And Inhibition Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib On Cervical Carcinoma In Vitro
31. Mechanism On The Treatment Of Autosomal Polycystic Kidney Disease With Roglitazone: Role Of ERK1/2 Signal Pathway
32. A Study On Airway Remodeling Of Chronic Asthmatic Mouse Model Intervened By Muti-receptor Tyrosine Kinase Inhibitor
33. Studies On The Synthesis And Cytotoxicity Of Dasatinib Analogues As Pan-Src Kinase Inhibitor
34. Evaluation Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor To Treat Patients With Advanced Non-small Cell Lung Cancer And Preliminary Study Of DNA Methylation In Lung Cancer Metastasis
35. Study On PCL Based Micro/nanoparticles For Drug Delivery
36. Mutations In EGFR Gene Associated With Tyrosine Kinase Inhibitor Response In Advanced Non-small-cell Lung Cancer
37. Small Molecule Tyrosine Kinase Inhibitor ZD6474 On Hepatocellular Cells And Its Mechanism
38. Synthesis And Pharmacological Activity Of Protein Tyrosine Kinase Inhibitor AW1
39. Design And Synthesis Study Of 2-indolinone Derivatives As Inhibitors Of Receptor Tyrosine Kinase And The Screening Of Compoud-activities
40. Comparing ARMS And Sequencing In Detecting EGFR Mutation And The Prediction Of EGFR-TKI Response In NSCLCs
  <<First  <Prev  Next>  Last>>  Jump to